Stocks
Iovance Biotherapeutics (IOVA) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -35 949% | -214.3% | -135.5% | -114.4% | ||||
| Changes by years, y/y, % | +35 735pp | +79pp | -93.9% | ||||||
Iovance Biotherapeutics. EBITDA margin, %
Iovance Biotherapeutics. EBITDA margin, changes, pp
Iovance Biotherapeutics (IOVA) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -216.8% | -163.0% | -125.5% | -78.1% | -99.6% | -114.4% | |
| Changes by years, y/y, % | +14 862pp | +130pp | +8pp | +23pp | +117pp | |||
| Changes by quarters, q/q, % | -115pp | +54pp | +38pp | +47pp | -22pp | |||
